Harbin Gloria Pharmaceuticals Co., Ltd
SHZ: 002437.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Leifeng Guo
- Employees
- 3,085
- Headquarters
- Harbin, China
- IPO year
- 2011
- Market cap
- CN¥7.4B
- Website
- https://www.gloria.cc
Loading 002437…
Loading profile data…Frequently asked questions about 002437
What does Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) do?
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective...
Where does 002437.SZ trade?
Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002437.SZ in?
Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Harbin Gloria Pharmaceuticals Co., Ltd?
Leifeng Guo is the chief executive officer of Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ).
Where is Harbin Gloria Pharmaceuticals Co., Ltd headquartered?
Harbin Gloria Pharmaceuticals Co., Ltd is headquartered in China.
Does 002437.SZ pay a dividend?
Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 002437.SZ go public?
Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) completed its initial public offering in 2011.